TRACON PHARMS INC (TCON) earnings

Quarterly and annual TCON reports and results, each read against the price at its own news timestamp. Back to the TCON overview →

8 measured TCON earnings events.

DateHeadlineEvent5-minTo close
Form 10-Q Tracon Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q+0.00%+25.56%
Form 10-Q Tracon Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q+3.19%+1.25%
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatePress release+3.19%+1.25%
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024Press release+0.00%-2.76%
Form 10-K Tracon Pharmaceuticals, For: Dec 31SEC filing · Form 10-K-1.30%-1.50%
Form 10-Q Tracon Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q+5.66%-23.74%
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatePress release+5.66%-23.74%
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023Press release+0.35%-2.84%
Get an email when TCON moves on news →
Keep exploring

More TCON: analyst actions → · SEC filings → · TCON overview →

Other Healthcare names and their earnings

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.